Non-Strauss | Strauss | Test value | P-value | Sig. | |
---|---|---|---|---|---|
No. = 37 | No. = 30 | ||||
Age | |||||
Mean ± SD | 62.97 ± 5.69 | 62.07 ± 6.08 | 0.629• | 0.532 | NS |
Range | 52–74 | 52–73 | |||
Gender | |||||
Male | 24 (64.9%) | 15 (50.0%) | 1.505* | 0.220 | NS |
Female | 13 (35.1%) | 15 (50.0%) | |||
BMI | |||||
Mean ± SD | 30.00 ± 3.25 | 32.07 ± 5.60 | − 1.890• | 0.063 | NS |
Range | 24–37 | 24–46 | |||
Diabetes | |||||
Yes | 22 (59.5%) | 18 (60.0%) | 0.002* | 0.964 | NS |
HTN | |||||
Yes | 18 (48.6%) | 26 (86.7%) | 10.622* | 0.001 | HS |
CKD | |||||
eGFR > 60 | 33 (89.2%) | 24 (80%) | 9.395* | 0.009 | HS |
eGFR30-60 | 4 (10.8%) | 6 (20.0%) | |||
Cardiomyopathy | |||||
DCM | 21 (56.8%) | 13 (43.3%) | 1.194* | 0.274 | NS |
ICM | 16 (43.2%) | 17 (56.7%) | |||
ACEI | |||||
Yes | 27 (73.0%) | 24 (80.0%) | 0.450* | 0.502 | NS |
ARNI | |||||
Yes | 4 (10.8%) | 3 (10.0%) | 0.012* | 0.914 | NS |
BB | |||||
Yes | 37 (100.0%) | 30 (100.0%) | NA | NA | NS |
Diuretics | |||||
Yes | 37 (100.0%) | 27 (90.0%) | 3.873* | 0.049 | S |
MRAs | |||||
Yes | 23 (62.2%) | 21 (70.0%) | 0.451* | 0.502 | NS |
SGLT2 inh | |||||
Yes | 4 (10.8%) | 4 (13.3%) | 0.100* | 0.752 | NS |
QRS duration (msec) | |||||
Mean ± SD | 134.32 ± 7.65 | 166.33 ± 22.05 | − 8.251• | < 0.001 | HS |
Range | 130–160 | 140–200 | |||
NYHA improvement | |||||
No | 10 (27.8%) | 6 (20.0%) | 9.562* | 0.023 | S |
One-class | 23 (63.9%) | 12 (40.0%) | |||
Two-class | 3 (8.3%) | 11 (36.7%) | |||
Three-class | 0 (0.0%) | 1 (3.3%) | |||
ESV reduction | |||||
Mean ± SD | 15.63 ± 2.34 | 17.92 ± 4.47 | 3.352• | 0.023 | S |
Range | 5–18 | 5–27 | |||
EF improvement by Simpson | |||||
Mean ± SD | 5.81 ± 0.85 | 9.42 ± 3.05 | 5.801• | < 0.001 | HS |
Range | 5–8 | 6–15 | |||
GLS improvement | |||||
Median (IQR) | − 3 (− 4 to − 3) | − 6 (− 7 to − 4) | 4.732≠ | < 0.001 | HS |
Range | − 6–0 | − 11 to − 2 | |||
GCS improvement | |||||
Median (IQR) | − 3 (− 4 to − 2) | − 7 (− 8 to − 5) | 4.919≠ | < 0.001 | HS |
Range | − 7–0 | − 10 to − 2 | |||
6-month Hosp | |||||
Yes | 13 (35.1%) | 12 (40%) | 0.676* | 0.879 | NS |
Mortality | |||||
Yes | 1 (2.7%) | 0(0%) | 0.823* | 0.364 | NS |